Company profile: Kramer Labs
1.1 - Company Overview
Company description
- Provider of branded over-the-counter medicines in the foot care and cough-cold segments of the consumer healthcare market, offering products such as Nizoral A-D Anti-Dandruff Shampoo, Opti-Nail Fungal Nail Repair Pen, Kaopectate Diarrhea & Upset Stomach Reliever, Colace Stool Softener, Senokot laxatives, and NATURELO premium supplements.
Products and services
- Nizoral A-D Anti-Dandruff Shampoo: Shampoo containing ketoconazole 1% that controls flaking, scaling, and itching with a medicated, OTC-formulated profile
- Opti-Nail Fungal Nail Repair Pen: Pen-format treatment improving the appearance of nails affected by fungus with visible results in 2 days
- Senokot Laxatives: Vegetable-based laxatives delivering gentle, overnight relief from occasional constipation and offered in various strengths for tailored dosing
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Kramer Labs
OM Pharma
HQ: Switzerland
Website
- Description: Provider of microbial-derived immunotherapeutic products addressing acute and chronic immunological disorders from infections and inflammation, operating worldwide through partners and investing in R&D. Products include Broncho-Vaxom to regulate the immune system and prevent recurrent respiratory infections, Uro-Vaxom to treat and prevent recurrent lower urinary tract infections, and Dicynone for capillary hemorrhage prevention and treatment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OM Pharma company profile →
NanoCures
HQ: United States
Website
- Description: Provider of clinical-stage biotechnology and infectious disease immunity platforms, including: Cures Platform targeting specific genomic and molecular pathways to yield multiple therapeutics; Data/AI Platform using biometric, genomic, molecular, and environmental data with AI/ML to detect diseases early and guide new cure development; and Developer Platform offering resources, data, and tools to lower barriers and encourage innovation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoCures company profile →
UNION Therapeutics
HQ: Denmark
Website
- Description: Provider of clinical-stage pharmaceutical development of molecules with immunomodulatory and microbiological effects, focused on inflammatory skin disease and COVID-19. Developing Orismilast, a high-potency PDE4B/D inhibitor as an oral treatment for atopic dermatitis, hidradenitis suppurativa, psoriasis and ulcerative colitis, with Phase 2 studies (UCORIS in ulcerative colitis; IASOS in plaque psoriasis).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full UNION Therapeutics company profile →
BioMed Diagnostics
HQ: United States
Website
- Description: Provider of highly selective pre-plated prepared media culture devices that combine inoculation, culture, transport, and result analysis to reduce lab labor and costs. Solutions span clinical, veterinary point-of-care, and industrial microbiology for environmental monitoring and compliance, including InPouch, InTray, and PCR-compatible Transit Tube.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioMed Diagnostics company profile →
rqmicro
HQ: Switzerland
Website
- Description: Provider of rapid pathogen separation and detection technology for microbial assessment of water and food, delivering accurate results. Offers rqmicro.COUNT, a portable single-cell counting instrument, a cloud solution to organize microbiology data, application support, and test kits for intact cell count, total cell count, and quantitative E. coli detection in water.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full rqmicro company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Kramer Labs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Kramer Labs
2.2 - Growth funds investing in similar companies to Kramer Labs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Kramer Labs
4.2 - Public trading comparable groups for Kramer Labs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →